SavedAdd your journal

Journals / Molecular Oncologic Imaging / 2022 / Cilt: 2 - Sayı: 3

Treatment Response Evaluation by F-18 FDG PET/CT in Radioiodine Refractory Differentiated Carcinoma in a Case with Multiple Unusual Metastatic Lesions

Zehra Pınar KOÇ
Pelin Özcan KARA
Kadir ESER
Hamide SAYAR
İsa Burak GÜNEY
Pages
52–55
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case report is about the treatment response evaluation of a unique patient with multiple unusual metastatic lesions of RAIR-DTC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:F-18 FDG PET/CT has a documented role in diagnosis of the patients with radioiodine refractory differentiated thyroid carcinoma (RAIR-DTC) and there are ongoing studies about the treatment response evaluation for tyrosine kinase inhibitor treatment response evaluation.
📊
Key Findings & Data:F-18 FDG PET/CT has a documented role in diagnosis of the patients with radioiodine refractory differentiated thyroid carcinoma (RAIR-DTC) and there are ongoing studies about the treatment response evaluation for tyrosine kinase inhibitor treatment response evaluation.
💡
Conclusion & Impact:This case report is about the treatment response evaluation of a unique patient with multiple unusual metastatic lesions of RAIR-DTC.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:radioiodine refractory · treastment responce · fluorodeoxyglucose

Abstract

F-18 FDG PET/CT has a documented role in diagnosis of the patients with radioiodine refractory differentiated thyroid carcinoma (RAIR-DTC) and there are ongoing studies about the treatment response evaluation for tyrosine kinase inhibitor treatment response evaluation. This case report is about the treatment response evaluation of a unique patient with multiple unusual metastatic lesions of RAIR-DTC.

🔖

Cite This Article

KOÇ, Z. P., KARA, P. Ö., ESER, K., SAYAR, H., GÜNEY, İ. B. (2022). Treatment Response Evaluation by F-18 FDG PET/CT in Radioiodine Refractory Differentiated Carcinoma in a Case with Multiple Unusual Metastatic Lesions. Molecular Oncologic Imaging, Cilt: 2 - Sayı: 3, 52–55. https://ajindex.com/articles/861801

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Sakulpisuti, C., Charoenphun, P., & Chamroonrat, W. (2022). Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer. Molecules, 27(15), 4936. https://doi.org/10.3390/molecules271549362.
  2. Heydarzadeh, S., Moshtaghie, A. A., Daneshpoor, M., & Hedayati, M. (2020). Regulators of glucose uptake in thyroid cancer cell lines. Cell communication and signaling: CCS, 18(1), 83. https://doi.org/10.1186/s12964-020-00586-x3.
  3. Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., Schuff, K. G., Sherman, S. I., Sosa, J. A., Steward, D. L., Tuttle, R. M., & Wartofsky, L. (2016). 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid: official journal of the American Thyroid Association, 26(1), 1–133. https://doi.org/10.1089/thy.2015.00204.
  4. Takeuchi, S., Shiga, T., Hirata, K., Taguchi, J., Magota, K., Ariga, S., Gouda, T., Ohhara, Y., Homma, R., Shimizu, Y., Kinoshita, I., Tsuji, Y., Homma, A., Iijima, H., Tamaki, N., & Dosaka-Akita, H. (2018). Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study. BMJ open, 8(8), e021001. https://doi.org/10.1136/bmjopen-2017-0210015.
  5. Jannin, A., Lamartina, L., Moutarde, C., Djennaoui, M., Lion, G., Chevalier, B., Vantyghem, M. C., Deschamps, F., Hadoux, J., Baudin, E., Schlumberger, M., Leboulleux, S., & Do Cao, C. (2022). Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival. European journal of nuclear medicine and molecular imaging, 49(7), 2401–2413. https://doi.org/10.1007/s00259-022-05697-w6.
  6. Jain, T. K., Krishnaraju, V. S., Mittal, B. R., Sood, A., Kumar, R., Garg, R., & Kumar, S. (2021). Follicular Thyroid Carcinoma with Unusual Radioiodine-Refractory Breast Metastasis Mimicking Primary Breast Malignancy. Journal of nuclear medicine technology, 49(3), 288–289. https://doi.org/10.2967/jnmt.120.2592597.
  7. Cavaco, D., Fraga, D., & Ferreira, T. (2021). Coexistent thyroid and lung cancers resembling "flip-flop" phenomenon. Clinical case reports